We are a specialty CNS CRO that supports all phases of development for novel drugs. We provide scientific leadership and have extensive experience with the CNS approval process.
We are a specialty CNS CRO that supports all phases of development for novel drugs. We provide scientific leadership and have extensive experience with the CNS approval process.
We are a specialty CNS CRO that supports all phases of development for novel drugs. We provide scientific leadership and have extensive experience with the CNS approval process.
Our Scientific Leadership Team reviews every new protocol at the bid stage to assess the potential study risks, and works directly with the Sponsor as well as the CRO Project Teams to mitigate them in advance of FPI and then continues to be available throughout the life of the trial. Every Lotus Study is assigned a Scientific Leadership Team member from this list of Clinicians, Research Experts, and Scientists.
Lotus is a science-driven, full-service CRO with a number of unique qualities that no other CRO can provide. One particular differentiator is that we are under common ownership with Evolution Research Group (ERG), which is a clinical site organization with 20+ wholly-owned clinical research sites around the US.
Because of this connection to ERG, Lotus’ Sponsors benefit from one-stop shopping for:
We are very excited to introduce Erin Berg as our Director of Project Management at Lotus Clinical Research. In her role, Erin will be leveraging her
Lotus and ERG effectively kick off their inaugural internal CRA Academy! Cassie Witte asks the creator and facilitator of the CRA Academy, Marilyn Greenwalt, and
We are thrilled to introduce Sandra Winsett as the Director of Clinical Systems at Lotus Clinical Research! Sandra brings over 15 years of experience in
© 2023 Lotus Clinical Research, LLC. All Rights Reserved
